Literature DB >> 22151483

A consensus statement regarding the present suggested titration for prialt (ziconotide).

Robert Fisher, Sam Hassenbusch, Elliot Krames, Michael Leong, Michael Minehart, Joshua Prager, Peter Staats, Lynn Webster, K Dean Willis.   

Abstract

Entities:  

Year:  2005        PMID： 22151483     DOI： 10.1111/j.1525-1403.2005.05232.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN： 1094-7159


× No keyword cloud information.
  10 in total

1.  High-Voltage-Activated Calcium Channel in the Afferent Pain Pathway: An Important Target of Pain Therapies.

Authors:  Qi Li; Jian Lu; Xiaoxin Zhou; Xuemei Chen; Diansan Su; Xiyao Gu; Weifeng Yu
Journal:  Neurosci Bull       Date:  2019-05-07       Impact factor: 5.203

Review 2.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 3.  Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain.

Authors:  Michael Saulino; Philip S Kim; Erik Shaw
Journal:  J Pain Res       Date:  2014-11-10       Impact factor: 3.133

Review 4.  Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain.

Authors:  Gladstone C McDowell; Jason E Pope
Journal:  Neuromodulation       Date:  2016-02-09

Review 5.  Ziconotide Monotherapy: A Systematic Review of Randomised Controlled Trials.

Authors:  Morag E Brookes; Sam Eldabe; Alan Batterham
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 6.  Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options.

Authors:  Timothy R Deer; Jason E Pope; Michael C Hanes; Gladstone C McDowell
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750

7.  Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.

Authors:  Howard S Smith; Timothy R Deer
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

8.  Ziconotide-induced psychosis: A case report and literature review.

Authors:  Gary Burdge; Henry Leach; Kim Walsh
Journal:  Ment Health Clin       Date:  2018-08-30

9.  Intrathecal pain management with ziconotide: Time for consensus?

Authors:  Georgios Matis; Pasquale De Negri; Denis Dupoiron; Rudolf Likar; Xander Zuidema; Dirk Rasche
Journal:  Brain Behav       Date:  2021-03       Impact factor: 2.708

10.  [What became of Prialt®? : Observational study on the use of ziconotide in the treatment of chronic pain].

Authors:  Denise Löschner; Rebecca Dries; Rolf Kalff; Jan Walter; Rupert Reichart
Journal:  Schmerz       Date:  2021-01-28       Impact factor: 1.107
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.